Trial Profile
Exploration of the Physiological Effect of GLP-1 in Obese Adults Diagnosed With Obesity Causing Genetic Mutations
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 12 May 2020 Status changed from active, no longer recruiting to completed.
- 02 May 2018 Planned End Date changed from 1 May 2018 to 1 Apr 2019.
- 11 May 2016 Planned End Date changed from 1 May 2017 to 1 May 2018.